LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX)

Historical Holders from Q1 2021 to Q3 2025

Symbol
LVTX on Nasdaq
CUSIP
N51517105
Type / Class
Equity / Common shares, Euro 0.12 nominal value per share
Shares outstanding
26.3M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
8.05M
Holdings value
$10.6M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
19
Number of buys
5
Number of sells
-8
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cooperatieve Gilde Healthcare IV U.A. 11.2% -43.5% $4.69M -$3.65M 2.95M -43.8% Cooperatieve Gilde Healthcare IV U.A. Oct 15, 2025
Shay Capital LLC 9.9% $3.97M 2.6M Shay Capital LLC Sep 19, 2025
BML Investment Partners, L.P. 7.4% $2.45M 1.96M BML Investment Partners, L.P. Feb 26, 2025

Institutional Holders of LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 26 $40.00 -$135K $1.54 1
2025 Q2 8.05M $10.6M -$2.39K $1.32 19
2025 Q1 8.04M $10.2M +$2.03M $1.27 20
2024 Q4 6.47M $6.15M -$432K $0.95 21
2024 Q3 3.61M $5.99M -$253K $1.66 20
2024 Q2 3.76M $6.77M -$68.2K $1.80 19
2024 Q1 3.76M $12.5M +$2.29M $3.33 21
2023 Q4 400 $1K $0 $2.04 2
2023 Q3 400 $1K -$23K $2.00 2
2023 Q2 5.75M $11.7M -$1.82M $2.03 15
2023 Q1 6.74M $11.2M -$1.1M $1.66 18
2022 Q4 7.37M $25.8M -$426K $3.50 17
2022 Q3 7.45M $34.1M -$58.9K $4.57 12
2022 Q2 7.84M $22.8M -$450K $2.95 16
2022 Q1 8M $35.2M -$409K $4.40 16
2021 Q4 8.05M $44.3M -$912K $5.50 18
2021 Q3 8.22M $48.6M -$5.13M $5.92 17
2021 Q2 8.77M $95.5M -$2.96M $10.88 18
2021 Q1 9.22M $139M +$139M $15.19 24